Omega-3 fatty acid supplementation affects tryptophan metabolism during a 12-week endurance training in amateur runners: a randomized controlled trial

被引:0
|
作者
Maja Tomczyk
Monika Bidzan-Wiącek
Jakub Antoni Kortas
Magdalena Kochanowicz
Zbigniew Jost
Helena L. Fisk
Philip C. Calder
Jędrzej Antosiewicz
机构
[1] Gdansk University of Physical Education and Sport,Department of Biochemistry
[2] Medical University of Gdansk,Department of Bioenergetics and Physiology of Exercise
[3] Gdansk University of Physical Education and Sport,Department of Biomechanics and Sports Engineering
[4] Medical University of Gdansk,Department of Physiotherapy
[5] University of Southampton,School of Human Development and Health, Faculty of Medicine
[6] University Hospital Southampton NHS Foundation Trust and University of Southampton,NIHR Southampton Biomedical Research Centre
来源
关键词
Omega-3 fatty acids; Endurance training; Tryptophan metabolism; 3-hydroxykynurenine; Picolinic acid;
D O I
暂无
中图分类号
学科分类号
摘要
The effects of long-term omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation during endurance training on tryptophan (Trp) metabolism and mental state of healthy individuals have not been evaluated so far. Concentrations of plasma Trp, its metabolites and IL-6 were assessed in 26 male runners before and after a 12-week training program combined with supplementation of n-3 PUFAs (O-3 + TRAIN group) or medium chain triglycerides (MCTs; TRAIN group). After the 12-week program participants' mood before and after stress induction was also assessed. The effects of the same supplementation protocol were evaluated also in 14 inactive subjects (O-3 + SEDEN group). Concentrations of 3-hydroxykynurenine (3-HK) and picolinic acid (PA) significantly increased only in the O-3 + TRAIN group (p = 0.01; ηp2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\eta }_{p}^{2}$$\end{document} = 0.22 and p = 0.01; ηp2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\eta }_{p }^{2}$$\end{document}= 0.26). Favorable, but not statistically significant changes in the concentrations of kynurenic acid (KYNA) (p = 0.06; ηp2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\eta }_{p }^{2}$$\end{document}= 0.14), xanthurenic acid (XA) (p = 0.07; ηp2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\eta }_{p }^{2}$$\end{document}= 0.13) and 3-hydroxyanthranilic acid (3-HAA) (p = 0.06; ηp2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$${\eta }_{p }^{2}$$\end{document}= 0.15) and in the ratio of neurotoxic to neuroprotective metabolites were seen also only in the O-3 + TRAIN group. No changes in mood and IL-6 concentrations were observed in either group. Supplementation with n-3 PUFAs during endurance training has beneficial effects on Trp's neuroprotective metabolites.
引用
收藏
相关论文
共 50 条
  • [31] Randomized Controlled Trial of Omega-3 and-6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder
    Keim, Sarah A.
    Jude, Abigail
    Smith, Katie
    Khan, Aiman Q.
    Coury, Daniel L.
    Rausch, Joseph
    Udaipuria, Shivika
    Norris, Megan
    Bartram, Lindsay R.
    Narayanan, Anita R.
    Rogers, Lynette K.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2022, 52 (12) : 5342 - 5355
  • [32] Omega-3 and-6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial
    Boone, Kelly M.
    Gracious, Barbara
    Klebanoff, Mark A.
    Rogers, Lynette K.
    Rausch, Joseph
    Coury, Daniel L.
    Keim, Sarah A.
    EARLY HUMAN DEVELOPMENT, 2017, 115 : 64 - 70
  • [33] Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial
    Simmonds, L. A.
    Sullivan, T. R.
    Skubisz, M.
    Middleton, P. F.
    Best, K. P.
    Yelland, L. N.
    Quinlivan, J.
    Zhou, S. J.
    Liu, G.
    McPhee, A. J.
    Gibson, R. A.
    Makrides, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (08) : 975 - 981
  • [34] No effect of omega-3 polyunsaturated fatty acid supplementation on inflammatory markers in familial hypercholesterolemia: a randomized crossover trial
    Hande, Liv Nesse
    Thunhaug, Hilde
    Ludviksen, Judith
    Hovland, Anders
    Lappegard, Knut Tore
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (03): : 152 - 159
  • [35] Effects of 12-Week Multivitamin and Omega-3 Supplementation on Micronutrient Levels and Red Blood Cell Fatty Acids in Pre-menopausal Women
    Osburn, Shelby C. C.
    Roberson, Paul A. A.
    Medler, Jessica A. A.
    Shake, Jacob
    Arnold, Robert D. D.
    Alamdari, Nima
    Bucci, Luke R. R.
    Vance, Arianne
    Sharafi, Mastaneh
    Young, Kaelin C. C.
    Roberts, Michael D. D.
    FRONTIERS IN NUTRITION, 2021, 8
  • [36] Feasibility of omega-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
    Ashley S Fulton
    Alison M Hill
    Marie T Williams
    Peter RC Howe
    Peter A Frith
    Lisa G Wood
    Manohar L Garg
    Alison M Coates
    Trials, 14
  • [37] Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial
    Haghiac, Maricela
    Yang, Xiao-hua
    Presley, Larraine
    Smith, Shoi
    Dettelback, Shirley
    Minium, Judi
    Belury, Martha A.
    Catalano, Patrick M.
    Hauguel-de Mouzon, Sylvie
    PLOS ONE, 2015, 10 (09):
  • [38] Feasibility of omega-3 fatty acid supplementation as an adjunct therapy for people with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
    Fulton, Ashley S.
    Hill, Alison M.
    Williams, Marie T.
    Howe, Peter Rc
    Frith, Peter A.
    Wood, Lisa G.
    Garg, Manohar L.
    Coates, Alison M.
    TRIALS, 2013, 14 : 107
  • [39] Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial
    Soleimani, Alireza
    Taghizadeh, Mohsen
    Bahmani, Fereshteh
    Badroj, Negin
    Asemi, Zatollah
    CLINICAL NUTRITION, 2017, 36 (01) : 79 - 84
  • [40] Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Cytokines and Advanced Glycation End Products in Patients With Diabetic Nephropathy A Randomized Controlled Trial
    Mirhashemi, Seyyed Mehdi
    Rahimi, Faeze
    Soleimani, Alireza
    Asemi, Zatollah
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (04) : 197 - 204